Why Sezzle's shares may be overvalued
Sezzle, the US buy-now-pay-later provider, is resting on shaky foundations. Is it time to sell this stock?
One of the most controversial areas of the financial technology (fintech) sector is buy-now-pay-later, or BNPL. Like traditional consumer financing schemes, BNPL allows a firms’ customers to buy goods without paying for them upfront; the company essentially lends them the purchase price. However, instead of the company having to provide the capital, and take on the risk that the purchaser won’t be able to pay, a BNPL provider uses its own money, assuming the credit risk, in exchange for a cut of the sale price.
BNPL’s supporters argue that it can be a win for all concerned, with consumers getting hassle-free access to a wider range of goods and merchants making more sales. Of course, BNPL firms hope that the money they get from the loans and merchant fees will more than compensate for any defaults. It has certainly proved popular, with research suggesting that the value of BNPL loans in the US will eclipse $100 billion for the first time in 2025. However, the worry is that it may encourage people to borrow beyond their means. What’s more, from an investor’s point of view, the quality of some of the loans that BNPL firms provide are a cause for concern.
A case in point is the American BNPL provider Sezzle (Nasdaq: SEZL). Originally listed in Australia, Sezzle changed its listing to the US 15 months ago. Between May and November 2024 the share price rose tenfold thanks to soaring revenue growth and the fact that it now says that it is making money. However, sceptics, such as short seller Hindenburg Research, argue that these profits depend on whether it is correctly estimating the percentage of loans that will default. If the loans do worse than expected – either thanks to bad lending practices or a general economic downturn – then these profits could very quickly disappear.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The quality of the loan book isn’t the only thing investors are worried about. All the evidence suggests that the number of merchants signed up with Sezzle has actually gone down over the past three years, with several partnerships with major companies such as Target failing to materialise. There have also been complaints about Sezzle allegedly making it very easy for users to sign up to its premium subscription service by accident.
Are Sezzle's shares overvalued?
The shares look overvalued too. They are on 24.5 trailing earnings and a price-to-sales ratio of 5.75, which is relatively high for a technology firm, and higher than most other BNPL firms.
There are also signs that the market is beginning to reconsider Sezzle, especially after it decided to issue some more shares in November, possibly suggesting that even Sezzle’s management thinks it is overvalued, or that it wants to have more cash on hand to cover losses from loans. Already Sezzle is down by more than half from its November peak. With the company now trading well below its 50-day moving average, I suggest shorting it at the current price of $228 at £10 per $1. In that case, cover your position if it went above $318, which gives you a total downside of £900.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
Matthew graduated from the University of Durham in 2004; he then gained an MSc, followed by a PhD at the London School of Economics.
He has previously written for a wide range of publications, including the Guardian and the Economist, and also helped to run a newsletter on terrorism. He has spent time at Lehman Brothers, Citigroup and the consultancy Lombard Street Research.
Matthew is the author of Superinvestors: Lessons from the greatest investors in history, published by Harriman House, which has been translated into several languages. His second book, Investing Explained: The Accessible Guide to Building an Investment Portfolio, is published by Kogan Page.
As senior writer, he writes the shares and politics & economics pages, as well as weekly Blowing It and Great Frauds in History columns He also writes a fortnightly reviews page and trading tips, as well as regular cover stories and multi-page investment focus features.
Follow Matthew on Twitter: @DrMatthewPartri
-
Average pension pot by age
How does your pension pot compare to your peers? We delve into the data and reveal the average pension pot for different age groups
By Ruth Emery Published
-
Should you invest in Netflix?
Netflix opened almost 15% higher today (22 January) after the company beat revenue expectations and smashed subscriber forecasts. Should you invest in the streaming giant?
By Katie Williams Published
-
MoneyWeek's trading tips - how did they fare in 2024?
My tips have yielded a profit and the open positions are proving lucrative, too
By Dr Matthew Partridge Published
-
Should you invest in Trainline?
Ticket seller Trainline offers a useful service – and good prospects for investors
By Dr Matthew Partridge Published
-
Harworth doubles profit as revenue soars – should you buy?
Harworth, a specialist property developer, is well-aligned with government policies, with revenue expected to rise by over 50% this year, and a further 30% the year after.
By Dr Matthew Partridge Published
-
Bitcoin miner Riot Platforms bleeds money – what happens now?
Riot Platforms struggles to make a profit and looks absurdly overvalued. Are troubles brewing?
By Dr Matthew Partridge Published
-
M&S recovery has momentum: will it stick?
After years of decline, M&S seems to have turned a corner. But is this just a “dead cat bounce”?
By Dr Matthew Partridge Published
-
Is Alpha Group a good buy?
Alpha Group helps clients manage risks such as foreign exchange. After being promoted to the London Stock Exchange, does the stock still rally?
By Dr Matthew Partridge Published
-
Vistry sales improve – should you buy into the boom?
Housebuilder Vistry’s unusual business model has fuelled rapid sales growth amid a sluggish private sales market
By Dr Matthew Partridge Published
-
Ocado shares plunge after FTSE 100 demotion
Ocado remains unprofitable and overvalued. Is it time to let go of the online supermarket?
By Dr Matthew Partridge Published